These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The status and prospects of immunological research in uveitis]. Zheng YZ Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):277-80. PubMed ID: 23866710 [TBL] [Abstract][Full Text] [Related]
5. [New methods of therapy for ocular inflammatory autoimmune diseases]. Kubicka-Trzaska A; Undas A Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272 [TBL] [Abstract][Full Text] [Related]
6. Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis. Broderick CA; Smith AJ; Balaggan KS; Georgiadis A; Buch PK; Trittibach PC; Barker SE; Sarra GM; Thrasher AJ; Dick AD; Ali RR Mol Ther; 2005 Aug; 12(2):369-73. PubMed ID: 16043105 [TBL] [Abstract][Full Text] [Related]
7. Relevance of animal models to human uveitis. Bodaghi B; Rao N Ophthalmic Res; 2008; 40(3-4):200-2. PubMed ID: 18421239 [TBL] [Abstract][Full Text] [Related]
9. [An update on uveitis]. Frau E Rev Prat; 1993 Nov; 43(17):2246-50. PubMed ID: 8146546 [TBL] [Abstract][Full Text] [Related]
10. [Problems and resolutions in the basic research of uveitis]. Yang PZ Zhonghua Yan Ke Za Zhi; 2011 May; 47(5):385-8. PubMed ID: 21756737 [TBL] [Abstract][Full Text] [Related]
11. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Nussenblatt RB Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3131-41. PubMed ID: 1748544 [No Abstract] [Full Text] [Related]
12. B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis. Liang W; Karabekian Z; Mattapallil M; Xu Q; Viley AM; Caspi R; Scott DW Clin Immunol; 2006 Jan; 118(1):35-41. PubMed ID: 16168712 [TBL] [Abstract][Full Text] [Related]
14. Regulatory T Cell Therapy for Uveitis: A New Promising Challenge. Foussat A; Gregoire S; Clerget-Chossat N; Terrada C; Asnagli H; Lemoine FM; Klatzmann D; LeHoang P; Forte M; Bodaghi B J Ocul Pharmacol Ther; 2017 May; 33(4):278-284. PubMed ID: 28448237 [TBL] [Abstract][Full Text] [Related]
15. Biologics in the treatment of uveitis. Imrie FR; Dick AD Curr Opin Ophthalmol; 2007 Nov; 18(6):481-6. PubMed ID: 18163000 [TBL] [Abstract][Full Text] [Related]
16. Serum PEDF levels are decreased in a spontaneous animal model for human autoimmune uveitis. Zipplies JK; Hauck SM; Schoeffmann S; Amann B; Stangassinger M; Ueffing M; Deeg CA J Proteome Res; 2009 Feb; 8(2):992-8. PubMed ID: 19113885 [TBL] [Abstract][Full Text] [Related]
17. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis. Mizuguchi J; Takeuchi M; Usui M Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620 [TBL] [Abstract][Full Text] [Related]
18. [Recent advances in clinical and basic studies of uveitis in China in the last five years]. Yang PZ; Xing L Zhonghua Yan Ke Za Zhi; 2005 Aug; 41(8):743-7. PubMed ID: 16191333 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic RNA interference for neurodegenerative diseases]. González-Alegre P Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881 [TBL] [Abstract][Full Text] [Related]
20. A systematic review of biologics for the treatment of noninfectious uveitis. Takeuchi M Immunotherapy; 2013 Jan; 5(1):91-102. PubMed ID: 23256801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]